Clinical Characteristics and Prognoses of Patients Treated Surgically for Metastatic Lung Tumors

Overview

Journal Oncotarget

Specialty Oncology

Date 2017 Feb 3

PMID 28148889

Citations 6

Authors

Xiaoliang Zhao

Xiaohua Wen

Wei Wei

Yulong Chen

Jianquan Zhu

Changli Wang

Affiliations

Soon will be listed here.

Abstract

The clinical characteristics of metastatic lung tumors are not well understood. To explore the surgical indications, surgical modes, and factors that influence postoperative outcomes, we analyzed clinical data from 42 patients with metastatic lung tumors who received surgical treatment at Tianjin Medical University Cancer Institute and Hospital between January 2000 and January 2014. Gender, age, nature of resections, surgical mode, smoking index, disease-free intervals (DFIs), number of metastatic lesions, and lymph node metastases were analyzed. Patients were followed for 6 to 98 months. We found that surgical treatment is feasible for resectable metastatic lung tumors, though postoperative radiochemotherapy had no significant effect on postoperative survival rates among patients with metastatic lung tumors. No patients died perioperatively. The 1-year, 3-year, and 5-year survival rates after surgical resection of metastatic lung tumors were 88.1%, 45.7%, and 34.6%, respectively. Univariate analysis indicated that DFIs and lymph node metastasis correlated with patient prognoses, while multivariate analysis indicated these two variables were independent prognostic factors. Thus surgical treatment may be indicated, depending on patients' specific condition, to lengthen DFIs in patients with metastatic lung tumors with or without evident lymph node metastasis.

Citing Articles

Unveiling the immunomodulatory dance: endothelial cells' function and their role in non-small cell lung cancer.

Daum S, Decristoforo L, Mousa M, Salcher S, Plattner C, Hosseinkhani B Mol Cancer. 2025; 24(1):21.

PMID: 39819502 PMC: 11737145. DOI: 10.1186/s12943-024-02221-6.

In Vivo PET Detection of Lung Micrometastasis in Mice by Targeting Endothelial VCAM-1 Using a Dual-Contrast PET/MRI Probe.

Melemenidis S, Knight J, Kersemans V, Perez-Balderas F, Zarghami N, Soto M Int J Mol Sci. 2024; 25(13).

PMID: 39000268 PMC: 11241628. DOI: 10.3390/ijms25137160.

The underappreciated role of resident epithelial cell populations in metastatic progression: contributions of the lung alveolar epithelium.

Christenson J, Williams M, Richer J Am J Physiol Cell Physiol. 2022; 323(6):C1777-C1790.

PMID: 36252127 PMC: 9744653. DOI: 10.1152/ajpcell.00181.2022.

Diagnostic Value of Bronchoscopy for Peripheral Metastatic Lung Tumors.

Tsujimoto Y, Matsumoto Y, Tanaka M, Imabayashi T, Uchimura K, Tsuchida T Cancers (Basel). 2022; 14(2).

PMID: 35053537 PMC: 8773960. DOI: 10.3390/cancers14020375.

Systemic Delivery of mLIGHT-Armed Myxoma Virus Is Therapeutic for Later-Stage Syngeneic Murine Lung Metastatic Osteosarcoma.

Christie J, Appel N, Zhang L, Lowe K, Kilbourne J, Daggett-Vondras J Cancers (Basel). 2022; 14(2).

PMID: 35053501 PMC: 8773855. DOI: 10.3390/cancers14020337.

References

Shiono S, Matsutani N, Okumura S, Nakajima J, Horio H, Kohno M . The prognostic impact of lymph-node dissection on lobectomy for pulmonary metastasis. Eur J Cardiothorac Surg. 2015; 48(4):616-21. DOI: 10.1093/ejcts/ezu533. View

Inoue M, Ohta M, Iuchi K, Matsumura A, Ideguchi K, Yasumitsu T . Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma. Ann Thorac Surg. 2004; 78(1):238-44. DOI: 10.1016/j.athoracsur.2004.02.017. View

Johnstone D, Byhardt R, Ettinger D, Scott C . Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy.... Int J Radiat Oncol Biol Phys. 2002; 54(2):365-9. DOI: 10.1016/s0360-3016(02)02943-7. View

Pastorino U, Buyse M, Friedel G, Ginsberg R, Girard P, Goldstraw P . Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg. 1997; 113(1):37-49. DOI: 10.1016/s0022-5223(97)70397-0. View

Hofmann H, Neef H, Krohe K, Andreev P, Silber R . Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Eur Urol. 2005; 48(1):77-81. DOI: 10.1016/j.eururo.2005.03.004. View

Mutsaerts E, Zoetmulder F, Meijer S, Baas P, Hart A, Rutgers E . Outcome of thoracoscopic pulmonary metastasectomy evaluated by confirmatory thoracotomy. Ann Thorac Surg. 2001; 72(1):230-3. DOI: 10.1016/s0003-4975(01)02629-7. View

Szkorupa M, Bohanes T, Neoral C, Chudacek J, Langova K . [Surgery of the pulmonary metastases]. Klin Onkol. 2013; 26(1):35-41. DOI: 10.14735/amko201335. View

Pfannschmidt J, Hoffmann H, Muley T, Krysa S, Trainer C, Dienemann H . Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg. 2002; 74(5):1653-7. DOI: 10.1016/s0003-4975(02)03803-1. View

Harpole Jr D, Johnson C, Wolfe W, George S, Seigler H . Analysis of 945 cases of pulmonary metastatic melanoma. J Thorac Cardiovasc Surg. 1992; 103(4):743-8; discussion 748-50. View

10.

Planchard D, Soria J, Michiels S, Grunenwald D, Validire P, Caliandro R . Uncertain benefit from surgery in patients with lung metastases from breast carcinoma. Cancer. 2003; 100(1):28-35. DOI: 10.1002/cncr.11881. View

11.

McCormack P, Ginsberg R . Current management of colorectal metastases to lung. Chest Surg Clin N Am. 1998; 8(1):119-26. View

12.

Patel A, Lamb J, Patel N, Santos R, Stavropoulos C, Landreneau R . Clinical trials for pulmonary metastasectomy. Semin Thorac Cardiovasc Surg. 2004; 15(4):457-63. DOI: 10.1053/j.semtcvs.2003.10.001. View

13.

Bolukbas S, Sponholz S, Kudelin N, Eberlein M, Schirren J . Risk factors for lymph node metastases and prognosticators of survival in patients undergoing pulmonary metastasectomy for colorectal cancer. Ann Thorac Surg. 2014; 97(6):1926-32. DOI: 10.1016/j.athoracsur.2014.02.026. View

14.

Monteiro A, Arce N, Bernardo J, Eugenio L, Antunes M . Surgical resection of lung metastases from epithelial tumors. Ann Thorac Surg. 2004; 77(2):431-7. DOI: 10.1016/j.athoracsur.2003.06.012. View

15.

DAVIDSON R, Nwogu C, Brentjens M, Anderson T . The surgical management of pulmonary metastasis: current concepts. Surg Oncol. 2001; 10(1-2):35-42. DOI: 10.1016/s0960-7404(01)00013-5. View

16.

Giulia Zampino M, Maisonneuve P, Ravenda P, Magni E, Casiraghi M, Solli P . Lung metastases from colorectal cancer: analysis of prognostic factors in a single institution study. Ann Thorac Surg. 2014; 98(4):1238-45. DOI: 10.1016/j.athoracsur.2014.05.048. View

17.

Hamaji M, Cassivi S, Shen K, Allen M, Nichols F, Deschamps C . Is lymph node dissection required in pulmonary metastasectomy for colorectal adenocarcinoma?. Ann Thorac Surg. 2012; 94(6):1796-800. DOI: 10.1016/j.athoracsur.2012.04.049. View

18.

Thomas M, Rube C, Hoffknecht P, Macha H, Freitag L, Linder A . Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer. Lancet Oncol. 2008; 9(7):636-48. DOI: 10.1016/S1470-2045(08)70156-6. View

19.

Tanada M, Nakata M, Kubo Y, Saeki H, Aogi K, Ishizaki M . [Pulmonary resection for metastatic colorectal cancer]. Gan To Kagaku Ryoho. 2002; 29(12):2135-7. View

20.

Ollila D, Stern S, Morton D . Tumor doubling time: a selection factor for pulmonary resection of metastatic melanoma. J Surg Oncol. 1999; 69(4):206-11. DOI: 10.1002/(sici)1096-9098(199812)69:4<206::aid-jso3>3.0.co;2-n. View